Whitehawk Therapeutics, Inc.
WHWK
$4.16
$0.051.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -9.41% | 32.60% | |||
| Gross Profit | 9.41% | -32.60% | |||
| SG&A Expenses | 7.23% | 12.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.48% | 27.33% | |||
| Operating Income | 5.48% | -27.33% | |||
| Income Before Tax | 4.55% | -31.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.55% | -31.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.55% | -31.02% | |||
| EBIT | 5.48% | -27.33% | |||
| EBITDA | 5.49% | -27.35% | |||
| EPS Basic | 4.55% | -31.01% | |||
| Normalized Basic EPS | 4.62% | -32.33% | |||
| EPS Diluted | 4.55% | -29.19% | |||
| Normalized Diluted EPS | 4.62% | -32.33% | |||
| Average Basic Shares Outstanding | 0.03% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||